Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
- Roth MKM analyst Jason Wittes initiated coverage on TriSalus Life Sciences, Inc. (NASDAQ:TLSI) with a Buy rating and announced a price target of $11. TriSalus Life Sciences shares closed at $4.23 on Friday. See how other analysts view this stock.
- Alliance Global Partners analyst James Molloy initiated coverage on GeoVax Labs, Inc. (NASDAQ:GOVX) with a Buy rating and announced a price target of $15. Geovax Labs shares closed at $1.95 on Friday. See how other analysts view this stock.
Considering buying GOVX stock? Here's what analysts think:
Read More:
- Dow, S&P 500 Notch Best Week Of Year As Tesla Surges Post Trump Win: Investor Sentiment Improves, Fear & Greed Index Remains In 'Neutral' Zone
